What do they all have in common?
They were all developed by YOUR Federal Government and YOUR Federal Tax Dollars.
Is there some reason they *some people* don't think we can do the same for Parkinson's, Diabetes, Alzheimers and anything else that stem cell research specifically embryonic stem cell research?
Is it really time to throw out such an effective and efficient model?
Why do they think we will fail? Do they hate America?
THAT is one of the main points of the whole embryonic stem cell research NON-issue. Yes they hide behind the thumpers and freaks (I'm tired of the PC terms for them) but they use their own model on this as every other issue-they put forth the supposedly righteous and the gullible to do the bidding of the "drown the government in a bathtub" Norquist types which actually is a ruse in and of itself.
See:
Vaccine Research and Development: The Key Roles of the National Institutes of Health and Other United States Government Agencies
See page 80 here
http://www.niaid.nih.gov/dmid/vaccines/jordan20/jordan20_2002.pdfINTRODUCTION diseases among children in the United States and other devel-The impact and importance of vaccines cannot be overstated— they provide safe, cost effective and efficient means of preventing
illness, disability and death from infectious diseases. Vaccines, along with the availability of improved medical care, living conditions, and sanitation, helped reduce mortality from infectious diseases in the Unites States more than 14-fold in the 20th century.
THE KEY ROLE OF BASIC RESEARCH
Basic biomedical research funded by NIH and other agencies underpins vaccine development. Historically, scientific advances
in microbiology and related disciplines have led to the development of new vaccines. For example, the identification of microbial toxins, as well as methods to inactivate them, allowed the development of some of our earliest vaccines, including those for diphtheria and tetanus. In the 1950s, new tissue culture techniques ushered in a new generation of vaccines, including those for polio, measles, mumps and rubella. In recent years we have seen rapid advances in our understanding of the immune system and the complex interactions between pathogens and the human host, as well as extraordinary technical advances such as recombinant DNA technology, gene sequencing and peptide synthesis. These developments have created opportunities for identifying new vaccine candidates to prevent diseases for which no vaccines currently exist; improving the safety and efficacy of existing vaccines; and designing novel vaccine approaches, such as new vectors and adjuvants.
NIH and other agencies actively pursue research portfolios that involve interaction with industry and academia and the transfer of technology to the private sector for commercialization.Table 1: Government Players in Vaccine Research
• CDC has a myriad of roles related to vaccines. Among them, the agency conducts the epidemiological studies and surveillance needed to define health priorities. In addition, CDC develops recommendations for vaccine use through the Advisory Committee for Immunization Practices (ACIP).
• DoD supports research into vaccines that likely will protect against pathogens that military personnel are likely to encounter.
• USAID supports research on vaccines of particular relevance to young children in developing countries.
• FDA establishes standards for the processes, facilities, and pre- and post-licensure activities needed to insure the safety and efficacy of vaccines.
• NIH supports, through its extramural and intramural programs, much of the basic research in microbiology and immunology that underpins vaccine development. NIH also provides research resources such as reagent repositories, genomic databases, and clinical trials support to identify vaccine targets and move candidates along the pathway to licensure. Sources: Folkers/Fauci, 1998; National Vaccine Advisory Committee, 1997